Follow-up for 9 months has shown no recurrence.
随访9个月，未见肿瘤复发。
The mean follow-up was 41 months with no recurrence.
术后平均随访41个月，无肿瘤复发。
Result: All cases were cured, and no recurrence happened.
结果：所有病例均治愈，无复发。
Results All cases lesion excision, no recurrence after operation.
结果所有患者均行病灶切除术，术后均无复发。
Results All cases were cured. No severe complication developed and no recurrence.
结果26例均痊愈出院，无心肺衰竭等严重并发症，无复发。
Results: There was no recurrence or tumor metastasis at a mean flow-up of 10 months.
结果：本组术后无外科并发症，平均随访10个月，无局部复发和肿瘤转移。
Follow-up of 9 months showed no recurrence of hematuria by anti-tuberculous treatment.
经抗结核治疗9个月，随访至今无血尿复发。
There is no recurrence in experimental group but 3 cases recurrence within 1 year in control group.
实验组无局部复发而对照组有3名患者术后1年内局部复发。
Results This group 48 patients were followed up for 6 ~ 50 months, no death, no wound infection, no recurrence.
结果对本组48例患者进行6 ~50个月随访，无死亡、无切口感染、无复发。
Results During the follow-up period of 2-18 months, all patients resumed a normal life and work, with no recurrence.
结果随访2 ~18个月，所有患者均恢复正常生活和工作，无1例复发。
Results Curative effect of different cases that adopted different combined therapies early was satisfying, no recurrence by follow-up visit.
结果不同的病例及早采用不同的方法综合治疗，效果满意，经随访无复发。
Results: 19 cases of acute sigmoid volvulus were treated by first stage resection and anastomosis, cured 19 cases, no recurrence and complications.
结果乙状结肠扭转一期切除吻合共19例，治愈19例，无复发和并发症发生。
No serious complications occurred. After following - up 12 to 39 months postoperatively, the symptoms vanished in all cases and no recurrence occurred.
全部病例均无严重并发症出现，术后随访12 ~39个月，术前症状均消失，无复发。
The patients were followed for 5-10 years. There was no recurrence, nor distant metastasis, and the functional recovery of extremities was satisfactory.
随访最短5年，最长10年，肿瘤无复发和转移，肢体功能恢复满意。
Results There was 25%recurrence rate in bone curettage and filling. There was no recurrence in diseased bone resection plus free fibular transplantation.
结果刮除、骨水泥充填术后复发率为25%，而游离腓骨移植病例无复发。
Results: During a follow-up of 12 to 24 months, no recurrence and no sub-epithelial fibro-vascular proliferation were found and all achieved a radical cure.
结果：术后随访12～24个月，所有患者未出现球结膜明显的纤维血管增生及角膜浸润，无1例复发。
Results: All children with clinical symptoms disappeared or reduced, nasopharyngeal mucosa smooth, non-residual adenoids, no recurrence, no complications arise.
结果：所有患儿临床症状消失或减轻，鼻咽部黏膜光滑，无腺样体残留，无复发，无并发症出现。
ResultsAll of 33 cases using vacuum sealing drainage postoperative had a healing wound. During the following up for 3 to 28 months, no recurrence of tuberculosis lesions was found.
结果术后使用持续封闭负压引流的33例腰椎结核病人伤口均一期愈合，随访3 ~28个月，无结核病灶复发。
Results: the tumor has been completely removed by laparoscopy for the carcinoma patient who showed improved symptoms after the surgery and no recurrence after half a year follow - up.
结果：本例肾上腺皮质癌患者经后腹腔镜将肿瘤完整切除，临床症状缓解，随访半年，无复发。
Results: 53 patients in this study recovered well after the using of narrow pedicle skin flap. All flaps survived and the appearance was satisfactory. And there was no recurrence of tumor.
结果：本组53例面部软组织缺损患者经窄蒂皮瓣修复后，全部治愈，皮瓣存活良好，外形满意，肿瘤病例无复发。
Result: 1 case underwent nephroureterectomy, 8 cases local resection plus pyeloplasty or ureterovesical replantation. 5 cases had been followed up for 2~74 months with no recurrence or canceration.
结果：1例行肾切除加输尿管大部分切除术，8例行病变输尿管节段性切除术加肾盂成形术或输尿管再植术。术后5例获随访2～ 74个月，未见息肉复发及恶变。
No recurrence was found in a follow-up of 6 to 12 months.
结果打鼾、鼻塞等症状消失或减轻，随访6～12个月无复发。
No recurrence of CSFL, intracranial infection and wound infection were noted.
无一例出现脑脊液漏复发、颅内感染和伤口感染等并发症。
No recurrence hemorrhage and severe complications were observed in 1 year follow-up.
术后随访1年，无复发出血及严重并发症发生。
No recurrence of infection, damage of nerve function or deep vein thrombosis of lower extremities occurred in all cases.
所有病例无感染复发、下肢神经功能损伤或深静脉栓塞形成等并发症。
No recurrence of lacrimal duct obstruction was found during follow up, and the recovery rate of dacryocystitis was 100%.
患侧泪道均未发生再次阻塞，泪囊炎治愈率为100%。
No recurrence of lacrimal duct obstruction was found during follow up, and the recovery rate of dacryocystitis was 100%.
患侧泪道均未发生再次阻塞，泪囊炎治愈率为100%。
应用推荐